Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
Active, not recruiting · NCT03443856 · Registry updated 2024-01-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence | Gastric and Esophagogastric Junction Adenocarcinoma | Active, not recruiting | Phase 2 | 2024-01-05 | NCT03443856 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 54 |
28 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.